SANTEN PHARMACEUTICAL CO., LTD.
4536・Prime Market・Pharmaceuticals
SANTEN PHARMACEUTICAL CO., LTD.4536
Recent Disclosures
| Date | Type | Title |
|---|---|---|
| 2026-10-27 | Other | Santen Announces Change of Major Shareholder |
| 2026-10-27 | Other | 主要株主の異動に関するお知らせ |
| 2026-10-16 | Other | Notice Regarding the Petition for Commencement of Bankruptcy Proceedings of a Consolidated Subsidiary |
| 2026-10-16 | Other | 当社連結子会社の破産手続開始申立てに関するお知らせ |
| 2026-09-30 | Other | Notice on the Completion of Disposal of Treasury Shares for the Post-delivery Type Performance-Linked Stock Remuneration Plan |
| 2026-09-30 | Other | 事後交付型業績連動株式報酬としての自己株式処分の払込完了に関するお知らせ |
| 2026-09-03 | Other | 事後交付型業績連動株式報酬としての自己株式の処分に関するお知らせ |
| 2026-09-03 | Other | Notice on the Disposal of Treasury Shares for the Post-delivery Type Performance-Linked Stock Remuneration Plan |
| 2026-08-06 | Other | Summary of Consolidated Financial Results for the Three Months Ended June 30, 2026 (IFRS) |
| 2026-08-06 | Earnings Report | 2027年３月期 第１四半期決算短信〔IFRS〕（連結） |